| Patents for A61K 31 - Medicinal preparations containing organic active ingredients (785,912) |
|---|
| 06/18/2008 | EP1931320A2 Microparticles with modified release of at least one active principle and oral galenic form comprising same |
| 06/18/2008 | EP1931315A2 Sustained release formulations of nalbuphine |
| 06/18/2008 | EP1931314A2 Ramipril formulation |
| 06/18/2008 | EP1931309A2 Antifungal composition |
| 06/18/2008 | EP1931308A2 Gelling hydrophobic injectable polymer compositions |
| 06/18/2008 | EP1931304A1 New use for a composition comprising chloroprocaine hcl, a new composition comprising chloroprocaine hcl and a method for its manufacture |
| 06/18/2008 | EP1931222A2 Gelling compositions and methods |
| 06/18/2008 | EP1931206A1 Improved anti-fungal composition |
| 06/18/2008 | EP1931205A2 Transglutaminase inhibitors and methods of use thereof |
| 06/18/2008 | EP1931201A2 Use of seh inhibitors as analgesics |
| 06/18/2008 | EP1931199A2 Treating renal disease, burns, wounds and spinal cord injury with selective androgen receptor modulators |
| 06/18/2008 | EP1853588B1 Chemical compounds |
| 06/18/2008 | EP1846401B1 New 4-aminoquinoline derivatives as antimalarials |
| 06/18/2008 | EP1843770B1 Solid particulate tadalafil having a bimodal particle size distribution |
| 06/18/2008 | EP1802625B1 Disubstituted pyrazolobenzodiazepines useful as inhibitors for cdk2 and angiogesis, and for the treatment of breast, colon, lung and prostate cancer |
| 06/18/2008 | EP1799186B1 Octenidine-containing lozenges used against inflammatory oral and pharyngeal diseases |
| 06/18/2008 | EP1687349B1 Polyamine polymers |
| 06/18/2008 | EP1684763B1 6-aryl-7-halo-imidazo[1,2-a]pyrimidines as anticancer agent |
| 06/18/2008 | EP1675853B1 Imidazo(4,5-b)pyridine-derivatives as inducible no-synthase inhibitors |
| 06/18/2008 | EP1617849B1 Composition and uses of galectin antagonists |
| 06/18/2008 | EP1617839B1 The use of azetidinecarboxamide derivatives in therapy |
| 06/18/2008 | EP1594861B1 Triazole compounds and the therapeutic use thereof |
| 06/18/2008 | EP1585521B1 Derivatives of aryl-quinazoline/aryl-2amino-phenyl methanone which promote the release of parathyroid hormone |
| 06/18/2008 | EP1585470A4 Transdermal delivery of fentanyl |
| 06/18/2008 | EP1583542B1 Compositions and methods for combination antiviral therapy |
| 06/18/2008 | EP1556359B1 Pyrazole derivatives and their use as therapeutic agents for hiv mediated diseases |
| 06/18/2008 | EP1513803B1 Ligands that are inhibitors of the rar receptors |
| 06/18/2008 | EP1496879A4 Regulation of a novel colon specific retinol dehydrogenase by apc and cdx2 |
| 06/18/2008 | EP1494656B1 Analgesic oral composition with controlled release of an opioid |
| 06/18/2008 | EP1487418B1 Co-beadlet of dha and rosemary and methods of use |
| 06/18/2008 | EP1485378B1 Piperazinyl-, piperidinyl- and morpholinyl-derivatives as novel inhibitors of histone deacetylase |
| 06/18/2008 | EP1443937B1 Substituted 1,4-benzodiazepines and uses thereof for the treatment of cancer |
| 06/18/2008 | EP1418922B1 Use of negatively charched phospholipids for the preparation of a medicament for treatment and/or prevention of macular degeneration |
| 06/18/2008 | EP1283830B1 Para-amine substituted phenylamide glucokinase activators |
| 06/18/2008 | EP1232160B1 Spiro(2h-1-benzopyran-2,4'-piperidine)derivates as glycine transport inhibitors |
| 06/18/2008 | EP1222192B1 Hexahydrofuro¬2,3-b furan-3-yl-n- 3-¬(1,3-benzodioxol-5-ylsulfonyl)(isobutyl)amino -1-benzyl-2-hydroxypropyl carbamate as retroviral protease inhibitor |
| 06/18/2008 | EP1181299B1 C-2 modified erythromycin derivatives |
| 06/18/2008 | EP1173464B1 Process for preparing a phytosterol composition |
| 06/18/2008 | EP1106176B1 Remedies for renal failure |
| 06/18/2008 | EP0885210B2 Tricylic compounds having binding affinity for melatonin receptors, their production and use |
| 06/18/2008 | CN201073138Y Bones health care composite pad |
| 06/18/2008 | CN101203615A Bacterial cellulose-containing formulations and method of producing effective bacterial cellulose-containing formulations |
| 06/18/2008 | CN101203549A Process for production of polymerized coordination compound of platinum complex |
| 06/18/2008 | CN101203526A Process for preparing 3alpha(beta)-7alpha(beta)-dihydroxy-6alpha(beta)-alkyl-5beta-cholanic acid |
| 06/18/2008 | CN101203521A Process for the preparation of N,N'-disubstituted oxabispidines |
| 06/18/2008 | CN101203519A 2-amido-6-amino-8-oxopurine derivatives as ToII-like receptor modulators for the treatment of cancer and viral infections, such as hepatitis c |
| 06/18/2008 | CN101203517A 1- ( 2-amino-3- (substituted alkyl)-3h-benzimidazoiylmethyl) -3-subtituted-1,3-dihydro-benzoimidazol-2-ones with activity on respiratory syncytial virus |
| 06/18/2008 | CN101203516A Purine and imidazopyridine derivatives for immunosuppression |
| 06/18/2008 | CN101203515A Pyrido[2,3-d]pyrimidines used as HCV inhibitors, and methods for the preparation thereof |
| 06/18/2008 | CN101203514A Substituted pyrido (2 , 3-d) pyrimidine derivatives useful as medicines for the treatment of autoimmune disorders |
| 06/18/2008 | CN101203513A Novel crystalline forms of tiotropium bromide |
| 06/18/2008 | CN101203512A Heterocyclic compound |
| 06/18/2008 | CN101203511A New azetidine derivatives as neurokinin receptor antagonists for the treatment of gastrointestinal diseases |
| 06/18/2008 | CN101203509A Amine-linked pyridyl and phenyl substituted piperazine-piperidines with CXCR3 antagonist activity |
| 06/18/2008 | CN101203508A Substituted pyrr0lidin-2-0nes , piperidin-2-0nes and isothiazolidine-1, 1-dioxides, their use as kvl .5 potassium channel blockers and pharmaceutical preparations comprising them |
| 06/18/2008 | CN101203507A 2-substituted benzimidazoles |
| 06/18/2008 | CN101203506A Heterocyclylaminoalkyl substituted benzimidazoles |
| 06/18/2008 | CN101203505A Chromane and chromene derivatives and uses thereof |
| 06/18/2008 | CN101203504A Antimicrobial agents |
| 06/18/2008 | CN101203503A Novel thiophene derivatives |
| 06/18/2008 | CN101203502A ( 6-flu0r0-benz0[l, 3] dioxolyl) -morpholin-4-yl-methanones and their use as cbl ligands |
| 06/18/2008 | CN101203501A Dihydrobenzofuranyl alkanamine derivatives as 5HT2C agonists |
| 06/18/2008 | CN101203500A Substituted arylamine compounds and uses as 5-HT6 moderator thereof |
| 06/18/2008 | CN101203499A Alkyl sulfonamide derivatives |
| 06/18/2008 | CN101203498A Heterocyclic anti-viral compounds comprising metabolizable moieties and their uses |
| 06/18/2008 | CN101203496A Process for preparing pure amorphous rosuvastatin calcium |
| 06/18/2008 | CN101203494A Methods of synthesizing substituted 3-cyanoquinolines and intermediates thereof |
| 06/18/2008 | CN101203493A Substituted heterocycles, their use as medicament, and pharmaceutical preparations comprising them |
| 06/18/2008 | CN101203492A Substituted butyrophenone derivatives |
| 06/18/2008 | CN101203489A Oxindole derivatives |
| 06/18/2008 | CN101203486A Dicarbonic acid derivatives, metastasis inhibitors and agents increasing chemotherapeutic activity of anti-tumor preparations, method for enhancing the efficiency of cytostatics and metastasis process |
| 06/18/2008 | CN101203483A N-substituted phenylacetamide derivative and pharmaceutical composition comprising the same |
| 06/18/2008 | CN101203481A Trihydroxy polyunsaturated eicosanoid derivatives |
| 06/18/2008 | CN101203270A Substances having body mass redistribution properties |
| 06/18/2008 | CN101203251A 玻璃体可视化剂 Vitreous visualization agent |
| 06/18/2008 | CN101203246A Medical composition |
| 06/18/2008 | CN101203245A Injection solution for RNA |
| 06/18/2008 | CN101203244A Compositions of rennin inhibitor and insulin secernent or insulin sensitizer |
| 06/18/2008 | CN101203243A Remedy for xanthoma |
| 06/18/2008 | CN101203230A Modulating angiogenesis with NOD factors such as glucosamine oligosaccharides |
| 06/18/2008 | CN101203229A Clarithromycin or salt thereof for the treatment or prevention of pulmonary disorders caused by the destruction of pulmonary alveoli |
| 06/18/2008 | CN101203228A Composition comprising isoorientin for suppressing histamine |
| 06/18/2008 | CN101203227A Ergotrophic lactone compound |
| 06/18/2008 | CN101203226A Compositions for the treatment of tumour |
| 06/18/2008 | CN101203225A Use of selective chloride ion channel modulators to treat alcohol and/or stimulant substance abuse |
| 06/18/2008 | CN101203224A Use of pyrimidylaminobenzamides for the treatment of diseases that respond to modulation of Tie-2 kinase activity |
| 06/18/2008 | CN101203223A Pharmaceutical composition comprising amorphous rosiglitazone |
| 06/18/2008 | CN101203222A Dermatological compositions and salts for the treatment of dermatological diseases |
| 06/18/2008 | CN101203221A Methods and compositions containing natural folates for protecting against radiation damage |
| 06/18/2008 | CN101203220A New use |
| 06/18/2008 | CN101203219A Anti-inflammatory modalities |
| 06/18/2008 | CN101203218A Benzofuranyl alkanamine derivatives and uses as 5-HT2C excitant thereof |
| 06/18/2008 | CN101203217A Methods for modulating bladder function |
| 06/18/2008 | CN101203216A Dihydrobenzofuran derivatives and uses thereof |
| 06/18/2008 | CN101203215A Ganglionic blocking agents for the treatment of epithelial diseases |
| 06/18/2008 | CN101203214A Beta-2 adrenoceptor agonists for treating connective tissue diseases of the skin |
| 06/18/2008 | CN101203134A Substituted arylpyrazoles as parasiticidal pharmaceutical product |
| 06/18/2008 | CN101200741A Synthesis of conjugated linoleic acid glyceride derivatives based on enzyme method |
| 06/18/2008 | CN101200719A Liver cancer related gene DLK1 and uses thereof |
| 06/18/2008 | CN101200488A Novel biogastrone acid derivatives, preparation method and medical uses thereof |